Literature DB >> 7166096

The competer automatic campimeter I. Technical description and evaluation.

R W de Boer, T J van den Berg.   

Abstract

We evaluated the perimetric concept and the technical construction of the Competer. The test procedures of the Competer are well conceived. The screening-strategy may fail in cases of central islands or large central defects. The interpretation of the visual field results is not easy, due to the use of a numerical print-out which, in addition, is different for screening and threshold examinations. The mechanical and electrical construction of the instrument could be improved. In the accompanying paper (Graniewski et al., 1982) results are presented of a comparative clinical evaluation.

Mesh:

Year:  1982        PMID: 7166096     DOI: 10.1007/bf00216790

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  13 in total

1.  An automatic perimeter for glaucoma visual field screening and control. Construction and clinical cases.

Authors:  A Heijl; C E Krakau
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-10-17

2.  Automatic computerized perimetry in the detection of neurological visual field defects. A pilot study.

Authors:  H Bynke; A Heijl
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-04-07

3.  Suprathreshold static perimetry. Initial clinical trials with the Fieldmaster automated perimeter.

Authors:  J L Keltner; C A Johnson; F G Balestrery
Journal:  Arch Ophthalmol       Date:  1979-02

4.  Computerized profile perimetry in glaucoma.

Authors:  A Heijl; S M Drance
Journal:  Arch Ophthalmol       Date:  1980-12

5.  The Friedmann Visual Field Analyser Mark II--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; M R Beintema; E L Greve; J Höppener; W M Verduin
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

6.  [Practical experiences with the Octopus automatic perimeter (author's transl)].

Authors:  J Spahr; F Fankhauser; A Jenni; H Bebie
Journal:  Klin Monbl Augenheilkd       Date:  1978-04       Impact factor: 0.700

7.  The fieldmaster 101 PR automatic visual field screener--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; E L Greve; H J Bos
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

8.  The competer automatic campimeter II. Clinical experience.

Authors:  H Graniewski-Wijnands; E L Greve; D Bakker; J L Moed
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

9.  The Ocuplot semi-automatic visual field screener--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; E L Greve; L J de Heer; P Wiercx
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

10.  Automatic perimetry in glaucoma visual field screening. A clinical study.

Authors:  A Heijl
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-07-26
View more
  5 in total

1.  The Friedmann Visual Field Analyser Mark II--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; M R Beintema; E L Greve; J Höppener; W M Verduin
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

2.  The fieldmaster 101 PR automatic visual field screener--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; E L Greve; H J Bos
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

3.  Performance of computer assisted perimeters.

Authors:  E L Greve
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

4.  The competer automatic campimeter II. Clinical experience.

Authors:  H Graniewski-Wijnands; E L Greve; D Bakker; J L Moed
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

5.  The Ocuplot semi-automatic visual field screener--technical evaluation and clinical results.

Authors:  R W de Boer; T J van den Berg; E L Greve; L J de Heer; P Wiercx
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.